Ken Griffin Clear Point Neuro, Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 22,600 shares of CLPT stock, worth $121,814. This represents 0.0% of its overall portfolio holdings.
Number of Shares
22,600
Previous 48,700
53.59%
Holding current value
$121,814
Previous $330,000
53.64%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CLPT
# of Institutions
82Shares Held
7.47MCall Options Held
83.2KPut Options Held
31.2K-
Black Rock Inc. New York, NY1.47MShares$7.94 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.31MShares$7.05 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA513KShares$2.77 Million0.0% of portfolio
-
Taylor Frigon Capital Management LLC424KShares$2.29 Million1.38% of portfolio
-
State Street Corp Boston, MA416KShares$2.24 Million0.0% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $132M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...